DarioHealth Corp. (NASDAQ:DRIO) Q4 2022 Results Conference Call March 9, 2023 8:30 PM ET
Company Participants
Glenn Garmont - Investor Relations
Erez Raphael - Chief Executive Officer
Rick Anderson - President
Conference Call Participants
Charles Rhyee - TD Cowen
Alexander Nowak - Craig-Hallum Capital Group
Rahul Rakhit - LifeSci Capital
Ben Haynor - Alliance Global Partners
David Grossman - Stifel
Operator
Greetings, and welcome to the DarioHealth Fourth Quarter 2022 Results Call. At this time, all participants are in a listen only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Glenn Garmont. Please go ahead, sir.
Glenn Garmont
Thank you, operator, and good morning, everybody. Thank you for joining us today for a discussion of DarioHealth's fourth quarter and full year 2022 financial results.
Leading the call today will be Erez Raphael, Chief Executive Officer of DarioHealth he'll be joined by Rick Anderson, President. After the prepared remarks, we'll open the call for Q&A. An audio recording and webcast replay for today's call will also be available online as detailed in the press release invite for this call. For the benefit of those who may be listening to the replay or archived webcast. This call is being held on March 9, 2023.
This morning, we issued a press release announcing our financial results for the fourth quarter and full year 2022. A copy of the release can be found on the Investor Relations page of DarioHealth's website. Actual events or results may differ materially from those projected as a result of changing market trends, reduced demand or the competitive nature of DarioHealth's industry. Such forward looking statements and their implications may involve known and unknown risks, uncertainties and other factors that may cause actual results
- Read more current DRIO analysis and news
- View all earnings call transcripts